List of Levoxyl drug patents

Levoxyl is owned by King Pharms.

Levoxyl contains Levothyroxine Sodium.

Levoxyl has a total of 3 drug patents out of which 2 drug patents have expired.

Expired drug patents of Levoxyl are:

  • US6555581
  • US7067148

Levoxyl was authorised for market use on 25 May, 2001.

Levoxyl is available in tablet;oral dosage forms.

Levoxyl can be used as method of use of administering levothyroxine.

The generics of Levoxyl are possible to be released after 02 October, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6555581 KING PHARMS Levothyroxine compositions and methods
Feb, 2022

(11 months ago)

US7067148 KING PHARMS Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Feb, 2022

(11 months ago)

US7101569 KING PHARMS Methods of administering levothyroxine pharmaceutical compositions
Oct, 2023

(8 months from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 25 May, 2001

Treatment: Method of use of administering levothyroxine

Dosage: TABLET;ORAL

How can I launch a generic of LEVOXYL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in